Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis

Table 4

ORR and severe AEs of different regimens in the AFP ≥ 20 ng/ml group.

ORR and AEs	Platinum-based doublet regimen ()	Taxane-based doublet regimen ()	Triplet regimen ()
PR	18 (43.9%)	3 (25.0%)	6 (66.7%)	0.162
SD + PD	23 (56.1%)	9 (75.0%)	3 (33.3%)
≥grade 3 AEs	9 (22.0%)	3 (25.0%)	6 (66.7%)	0.014

AE = adverse event; OS = overall survival.